IXC 0.00% 8.6¢ invex therapeutics ltd

Ann: Invex Granted Key European Patent for Exenatide, page-73

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,516 Posts.
    lightbulb Created with Sketch. 1283
    What steps to look for next based on quarterly.

    EMA/FDA
    https://hotcopper.com.au/data/attachments/3497/3497563-65098146113da3ab3bba883f22fa69ca.jpg

    Manufacturing
    https://hotcopper.com.au/data/attachments/3497/3497565-5268273f9aa9053b790ccc3f57b0452c.jpg

    Trademark
    https://hotcopper.com.au/data/attachments/3497/3497568-50128f83f25be6606d501ef0f83d73c3.jpg

    Lawsuit - is this why people are hesitant?
    https://hotcopper.com.au/data/attachments/3497/3497571-7c701b23ac2d92180b1b7a36c4c9a1c2.jpg


    So what is next by the looks of it is:
    1. Outcomes from discussions with key regulatory and scientific advisors
    2. Manufacturing finalisation - this should be the next catalyst to share price movement. Advanced discussions so should be close
    3. Trademark - European patent sorted. So US and Europe patent sorted.
    4. Lawsuit - invex not a party, but what I want to know is if University of Birmingham lose case to Exelogen does that affect Invex?

    Cheers
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.